Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• New trial data show mixed findings for omega-3s
• Margo B. Minissian, PhD, ANCP, discusses evolution of women’s CV health
• Cardiogenic shock: Defining the clinical and regulatory landscape Marc Samsky, MD
• Second-generation antidote for two direct oral anticoagulants approved
• Updated AF guidelines recommend newer oral anticoagulants for stroke prevention
• Anti-inflammatory psoriasis agents could reduce coronary artery plaque
• Apixaban plus aspirin may be beneficial after MitraClip implantation
• Aspirin increases risk for major bleeding, decreases CV risk in those without CVD
• Canakinumab not cost-effective to prevent recurrent CV events after MI
• Cardiac dysfunction prevalent in patients with HIV
• Hormone therapy increases risk for stroke, VTE in transgender women
• In HFrEF, women face poorer quality of life, receive less treatment vs. men
• Modifiable risk factors prevalent in young patients with MI
• AHA: Nearly half of all US adults have CVD
• Report: Cost, quality, development issues among barriers in fighting CVD
• Intensive BP control reduces risk for mild cognitive impairment
• Statin therapy reduces CV risks across age groups, including elderly
• Adding cilostazol to antiplatelet therapy reduces recurrent ischemic stroke risk
• ANNEXA-4: Andexanet alfa successfully reverses factor Xa inhibitor effects
• ISET town hall calls attention to paclitaxel-coated devices
• LIBERTY 360°: Endovascular interventions improve outcomes across all Rutherford classes
• Ultrasound-assisted, catheter-directed therapy for pulmonary embolism: Breaking down the evidence Dustin D. Spencer, PharmD, MBA, BCPS, BCCP; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• ARTEMIS
• DESERVE
• DEXACET
• ENCHANTED
• GATEWAY
• RESPECT
• SPRINT MIND
• UNCOVER-AF